Skip to main content

Table 1 Correlation between the clinicopathological features and expression of HOXD-AS1

From: Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling

clinicopathological variables N high(%) low(%) χ2 P value
All cases 150 56 94
Age
  < mean (56) 71 24 (33.8) 47 (66.2) 0.718 0.405
  ≥ mean (56) 79 32 (40.5) 47 (59.5)
Gender
 Male 89 33 (37.1) 56 (62.9)   
 Female 61 23 (37.7) 38 (62.3) 0.006 1
Tumor Size
  < 5 cm 96 40 (41.7) 56 (58.3) 2.14 0.162
  ≥ 5 cm 54 16 (29.6) 38 (70.4)
Tumor Differentiation
 Well 45 22 (48.9) 23 (51.1) 6.121 0.047
 Moderate 75 28 (37.3) 47 (62.7)
 Poor 30 6 (20.0) 24 (80.0)
T classification
 T1-T2 40 19 (47.5) 21 (52.5) 6.096 0.047
 T3 98 36 (36.7) 62 (63.3)
 T4 12 1 (8.3) 11 (91.7)
N classification
 N0 85 38 (44.7) 47 (55.3) 4.557 0.033
 N1-N2 65 18 (27.7) 47 (72.3)
M classification
 M0 113 48 (42.5) 65 (57.5) 4.637 0.031
 M1 37 8 (21.6) 29 (78.4)